Molecular Devices

Predict Toxicity Earlier

The EarlyTox™ Cardiotoxicity Kit provides a fast, simple, and reliable assay to predict compound toxicity and efficacy during lead optimization. Leveraging this proprietary kit with stem-cell derived cardiomyocytes, researchers can:

  • Study functional profiles in a biorelevant cardiotoxicity assay
  • Minimize non-specific effect of dye on beat characteristics
  • See temporal resolution with largest signal available
  • Measure 384 samples in minutes rather than hours

Download Application Highlight

To request a quote, demo or to have a salesperson contact you, please fill out the form below.

First Name* Last Name*
 
Email Address*
Company*
State/Province (or "International")*
Country*
Zip/Postal Code*
Request Quote*
Request Demo*
Have a Salesperson Contact Me*

By submitting this information, I confirm that I have read the Molecular Devices Privacy Policy, understand and agree to its terms.